No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪5.47 B‬EUR
‪59.32 M‬EUR
‪6.59 B‬EUR
‪291.12 M‬
Beta (1Y)


Nacho Abia
Employees (FY)
‪23.74 K‬
Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma for therapeutic use. The Hospital division offers non-biological pharmaceutical products and medical supplies for hospital pharmacy. The Diagnostic division provides clinical analysis and laboratory testing tools to laboratories, hospitals and blood banks. The Raw materials division includes sales of intermediate biological products, as well as manufacturing services to third parties. The Company operates production facilities in Spain, the United States, Mexico and Australia, among others. It controls numerous subsidiaries.
Revenue to profit conversion
Debt level and coverage

See all ideas 

Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GRF is 9.352 EUR — it has increased by 3.70% in the past 24 hours. Watch GRIFOLS S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BME exchange GRIFOLS S.A. stocks are traded under the ticker GRF.
GRF stock has fallen by 0.76% compared to the previous week, the month change is a 1.25% fall, over the last year GRIFOLS S.A. has showed a 18.00% decrease.
We've gathered analysts' opinions on GRIFOLS S.A. future price: according to them, GRF price has a max estimate of 25.00 EUR and a min estimate of 8.00 EUR. Watch GRF chart and read a more detailed GRIFOLS S.A. stock forecast: see what analysts think of GRIFOLS S.A. and suggest that you do with its stocks.
GRF reached its all-time high on Feb 21, 2020 with the price of 34.310 EUR, and its all-time low was 2.436 EUR and was reached on May 25, 2006. View more price dynamics on GRF chart.
See other stocks reaching their highest and lowest prices.
GRF stock is 5.20% volatile and has beta coefficient of 1.30. Track GRIFOLS S.A. stock price on the chart and check out the list of the most volatile stocks — is GRIFOLS S.A. there?
Today GRIFOLS S.A. has the market capitalization of ‪6.12 B‬, it has decreased by 2.14% over the last week.
Yes, you can track GRIFOLS S.A. financials in yearly and quarterly reports right on TradingView.
GRIFOLS S.A. is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
GRF earnings for the last quarter are 0.08 EUR per share, whereas the estimation was 0.10 EUR resulting in a −19.01% surprise. The estimated earnings for the next quarter are 0.21 EUR per share. See more details about GRIFOLS S.A. earnings.
GRIFOLS S.A. revenue for the last quarter amounts to ‪1.63 B‬ EUR, despite the estimated figure of ‪1.63 B‬ EUR. In the next quarter, revenue is expected to reach ‪1.82 B‬ EUR.
GRF net income for the last quarter is ‪55.99 M‬ EUR, while the quarter before that showed ‪59.54 M‬ EUR of net income which accounts for −5.96% change. Track more GRIFOLS S.A. financial stats to get the full picture.
GRIFOLS S.A. dividend yield was 0% in 2023, and payout ratio reached 0%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 13, 2024, the company has ‪23.74 K‬ employees. See our rating of the largest employees — is GRIFOLS S.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GRIFOLS S.A. EBITDA is ‪1.30 B‬ EUR, and current EBITDA margin is 17.90%. See more stats in GRIFOLS S.A. financial statements.
Like other stocks, GRF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRIFOLS S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GRIFOLS S.A. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GRIFOLS S.A. stock shows the sell signal. See more of GRIFOLS S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.